CD49f identifies stem-like memory T cells with enhanced therapeutic potency

The efficacy of adoptive cell therapies depends on the presence of T cells with durable self-renewal, proliferative capacity, and differentiation potential, yet heterogeneity within starting cell populations remains a major barrier to consistent clinical outcomes. Here, we identify CD49f as a marker of a unique subset of human memory T cells with stem-like characteristics. CD49f Hi memory CD8 + and CD4 + T cells exhibited transcriptional and phenotypic features associated with T cell stemness, including elevated LEF1, TCF1, CCR7, CD27, and CD28, while CD49f Lo cells exhibited effector-like transcriptional programs. Clinical evaluation of solid-organ transplant recipients treated with virus-specific T cells for cytomegalovirus complications demonstrated that autologous T cell therapies manufactured from CD49f Hi -enriched T cells were associated with superior immune reconstitution and greater in vivo expansion of CMV-specific T cells. Functional assays further revealed that CD49f Hi memory T cells possessed enhanced proliferative capacity and transcriptional plasticity following activation. Consistent with these findings, CD19 CAR T cells engineered from CD49f Hi memory T cells demonstrated improved persistence and conferred superior survival in a preclinical lymphoma model. Together, these findings establish CD49f as a marker of a stem-like memory T cell subset with enhanced therapeutic potential and identify CD49f Hi enrichment as a practical strategy to improve the consistency, durability, and clinical efficacy of both virus-specific and CAR T cell therapies.

Authors

Institutions

Publication Details

Journal
Proceedings of the National Academy of Sciences
Published
2026-11-18
DOI
https://doi.org/10.1073/pnas.2623940123
Primary Topic
T-cell and B-cell Immunology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

CD49f identifies stem-like memory T cells with enhanced therapeutic potency

José Paulo Martins, Corey Smith, Katie E. Lineburg, Rajiv Khanna et al.
1 links
Proceedings of the National Academy of Sciences
T-cell and B-cell Immunology
article

CD49f identifies stem-like memory T cells with enhanced therapeutic potency

José Paulo Martins, Corey Smith, Katie E. Lineburg, Rajiv Khanna, Archana Panikkar, Panteha Khaledi, Chi Wai Leung, Matthew Solomon, Thuy Le
article en

Abstract

The efficacy of adoptive cell therapies depends on the presence of T cells with durable self-renewal, proliferative capacity, and differentiation potential, yet heterogeneity within starting cell populations remains a major barrier to consistent clinical outcomes. Here, we identify CD49f as a marker of a unique subset of human memory T cells with stem-like characteristics. CD49f Hi memory CD8 + and CD4 + T cells exhibited transcriptional and phenotypic features associated with T cell stemness, including elevated LEF1, TCF1, CCR7, CD27, and CD28, while CD49f Lo cells exhibited effector-like transcriptional programs. Clinical evaluation of solid-organ transplant recipients treated with virus-specific T cells for cytomegalovirus complications demonstrated that autologous T cell therapies manufactured from CD49f Hi -enriched T cells were associated with superior immune reconstitution and greater in vivo expansion of CMV-specific T cells. Functional assays further revealed that CD49f Hi memory T cells possessed enhanced proliferative capacity and transcriptional plasticity following activation. Consistent with these findings, CD19 CAR T cells engineered from CD49f Hi memory T cells demonstrated improved persistence and conferred superior survival in a preclinical lymphoma model. Together, these findings establish CD49f as a marker of a stem-like memory T cell subset with enhanced therapeutic potential and identify CD49f Hi enrichment as a practical strategy to improve the consistency, durability, and clinical efficacy of both virus-specific and CAR T cell therapies.

Proceedings of the National Academy of SciencesVol. 123(47)
QIMR Berghofer Medical Research Institute (AU)
Good health and well-being
T-cell and B-cell Immunology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon